Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure
George, S, Blay, J.Y, Casali, P.G, Le Cesne, A, Stephenson, P, DePrimo, S.E, Harmon, C.S, Law, C.N.J, Morgan, J.A, Ray-Coquard, I, Tassell, V, Cohen, D.P, Demetri, G.D
Published in European journal of cancer (1990) (01.07.2009)
Published in European journal of cancer (1990) (01.07.2009)
Get full text
Journal Article
Stage 2 enrollment complete: Sitravatinib in combination with nivolumab in NSCLC patients progressing on prior checkpoint inhibitor therapy
Leal, T.A., Spira, A.I., Blakely, C., He, K., Berz, D., Richards, D., Uyeki, J., Savage, A., Roque, T., Massarelli, E., Jotte, R.M., Chen, I., Christensen, J., Olson, P., Tassell, V., Horn, L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
9084 POSTER A Global Phase 2 Study Including Efficacy, Safety and Patient-reported Outcomes (PROs) With Crizotinib in Patients (Pts) With ALK-positive Non-small Cell Lung Cancer (NSCLC)
Kim, D.W, Blackhall, F, Soria, J.C, Solomon, B, Camidge, D.R, Riely, G.J, Bottomley, A, Tassell, V, Polli, A, Shaw, A
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
5003 Phase II study of sunitinib in combination with trastuzumab for the treatment of metastatic breast cancer: activity and safety results
Blay, J.Y, Lluch, A, Gutierrez, M, Martin, M, Kozloff, M.F, Prady, C, Tassell, V, Kern, K, Huang, X, Verma, S
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
7501 ORAL Continuous daily dosing (CDD) study of sunitinib malate (SU) in patients (pts) with advanced GIST compares favorably with intermittent dosing
Blay, J.Y, George, S, Casali, P.G, Le Cesne, A, Morgan, J.A, Pokela, J, Quigley, M.T, Tassell, V, Baum, C.M, Demetri, G.D
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
1129OStage 2 enrollment complete: Sitravatinib in combination with nivolumab in NSCLC patients progressing on prior checkpoint inhibitor therapy
Leal, T A, Spira, A I, Blakely, C, He, K, Berz, D, Richards, D, Uyeki, J, Savage, A, Roque, T, Massarelli, E, Jotte, R M, Chen, I, Christensen, J, Olson, P, Tassell, V, Horn, L
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
P2.01-14 Phase 3 Trial of Sitravatinib Plus Nivolumab vs Docetaxel for Treatment of NSCLC After Platinum-Based Chemoimmunotherapy
Nidhiry, E., Mekhail, T., Thara, E., Nagasaka, M., Chen, C., Gopurala, B.G., Campbell, N., Eaton, K., Homsi, Y., Yanagihara, R., Vaddepally, R., Yan, X., Tassell, V., Neuteboom, S., Chao, R., Keresztes, R.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
Amethyst NSCLC trial: Phase 2, parallel-arm study of receptor tyrosine kinase (RTK) inhibitor, MGCD265 in patients with advanced or metastatic non-small cell lung cancer (NSCLC) with activating genetic alterations in mesenchymal-epithelial transition factor (MET)
Bazhenova, L., Mehra, R., Nagy, T., Cavanna, L., Lee, J.-S., Han, J.-Y., Kim, H.K., Halmos, B., Shum, M., Schreeder, M., Rybkin, I., Badin, F., Mena, R., Jänne, P.A., Christensen, J., Tassell, V., Chao, R., Faltaos, D., Kim, D.-W.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Phase III Study of Crizotinib Versus Pemetrexed or Docetaxel Chemotherapy in Patients with Advanced Alk-Positive Non-Small Cell Lung Cancer (NSCLC) (Profile 1007)
Shaw, A.T., Kim, D.W., Nakagawa, K., Seto, T., Crinò, L., Ahn, M., De Pas, T., Besse, B., Solomon, B., Blackhall, F.H., Wu, Y., Thomas, M., O'Byrne, K.J., Moro-Sibilot, D., Camidge, R., Hirsh, V., Mok, T.S.K., Tassell, V., Polli, A., Jänne, P.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Phase III trial of sunitinib (SU) in combination with capecitabine (C) versus C in previously treated advanced breast cancer (ABC)
Crown, J., Dieras, V., Staroslawska, E., Yardley, D. A., Davidson, N., Bachelot, T. D., Tassell, V. R., Huang, X., Kern, K. A., Romieu, G.
Published in Journal of clinical oncology (20.06.2010)
Published in Journal of clinical oncology (20.06.2010)
Get full text
Journal Article
Sunitinib (SU) in Combination with Trastuzumab (T) for the Treatment of Advanced Breast Cancer (ABC): Activity and Safety Results from a Phase II Study
Blay, J., Lluch, A., Gutierrez, M., Martin, M., Kozloff, M., Prady, C., Huang, X., Verkh, L., Chen, C., Tassell, V., Kern, K., Verma, S.
Published in Cancer research (Chicago, Ill.) (15.12.2009)
Published in Cancer research (Chicago, Ill.) (15.12.2009)
Get full text
Journal Article
Initial phase II results with crizotinib in advanced ALK -positive non-small cell lung cancer (NSCLC): PROFILE 1005
Crinò, L., Kim, D., Riely, G. J., Janne, P. A., Blackhall, F. H., Camidge, D. R., Hirsh, V., Mok, T., Solomon, B. J., Park, K., Gadgeel, S. M., Martins, R., Han, J., De Pas, T. M., Bottomley, A., Polli, A., Petersen, J., Tassell, V. R., Shaw, A. T.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Activity and safety of sunitinib in combination with trastuzumab for the treatment of metastatic breast cancer: initial results from a phase II study
Bachelot, T, Lluch, A, Gutierrez, M, Martin, MM, Kozloff, MF, Prady, C, Tassell, V, Kern, K, Huang, X, Verma, S, Blay, J
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Get full text
Journal Article
Novel statistical analysis of long-term survival to account for crossover in a phase III trial of sunitinib (SU) vs. placebo (PL) in advanced GIST after imatinib (IM) failure
Demetri, G. D., Huang, X., Garrett, C. R., Schöffski, P., Blackstein, M. E., Shah, M. H., Verweij, J., Tassell, V., Baum, C. M., Casali, P. G.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Continuous daily dosing (CDD) of sunitinib (SU) in pts with advanced GIST: Updated efficacy, safety, PK and pharmacodynamic analysis
George, S., Blay, J. Y., Casali, P. G., Le Cesne, A., DePrimo, S. E., Harmon, C. S., Law, C. N., Tassell, V., Baum, C. M., Demetri, G. D.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Continuous daily dosing (CDD) of sunitinib malate (SU) compares favorably with intermittent dosing in pts with advanced GIST
George, S., Blay, J. Y., Casali, P. G., Le Cesne, A., Morgan, J. A., Pokela, J., Quigley, M. T., Tassell, V., Baum, C. M., Demetri, G. D.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Phase II study of sunitinib administered in a continuous daily dosing regimen in patients (pts) with advanced GIST
George, S., Casali, P. G., Blay, J., Le Cesne, A., Tyler, A. R., Quigley, M. T., Tassell, V., Baum, C. M., Demetri, G. D.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Estrogen Increases Menopausal Host Susceptibility to Experimental Ascending Urinary-Tract Infection
Curran, Edward M., Tassell, Audrey Hart-Van, Judy, Barbara M., Nowicki, Bogdan, Montgomery-Rice, Valerie, Estes, D. Mark, Nowicki, Stella
Published in The Journal of infectious diseases (01.03.2007)
Published in The Journal of infectious diseases (01.03.2007)
Get full text
Journal Article